{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:53:35Z","timestamp":1790499215364,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neurol.2016.09.018","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T01:31:56Z","timestamp":1479346316000},"page":"8-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["French consensus. Management of patients with hypersomnia: Which strategy?"],"prefix":"10.1016","volume":"173","author":[{"given":"R.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Drouot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lecendreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2016.09.018_bib0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2016.09.018_bib0245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.5665\/sleep.3756","article-title":"Challenges in diagnosing narcolepsy without cataplexy: a consensus statement","volume":"37","author":"Baumann","year":"2014","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.smrv.2015.08.007","article-title":"Idiopathic hypersomnia","volume":"29","author":"Billiard","year":"2016","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neurol.2016.09.018_bib0255","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMra1500587","article-title":"Narcolepsy","volume":"373","author":"Campion","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0260","series-title":"International classification of sleep disorders\u2013third edition (ICSD-3)","author":"American Academy of Sleep Medicine","year":"2014"},{"key":"10.1016\/j.neurol.2016.09.018_bib0265","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-1331.2006.01473.x","article-title":"EFNS guidelines on management of narcolepsy","volume":"13","author":"Billiard","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0270","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/sleep\/24.4.385","article-title":"A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy","volume":"24","author":"Rogers","year":"2001","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0280","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/sleep\/17.suppl_8.S107","article-title":"Modafinil: a double-blind multicentric study","volume":"17","author":"Billiard","year":"1994","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0285","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.49.2.444","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy","volume":"49","author":"Broughton","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.09.018_bib0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","author":"Mitler","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0295","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","author":"US Modafinil in Narcolepsy Multicenter Study Group, others","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.09.018_bib0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1985","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0305","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"Vetter","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.neurol.2016.09.018_bib0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.smrv.2011.09.001","article-title":"Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Boscolo-Berto","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.neurol.2016.09.018_bib0315","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0320","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sleep.2012.07.008","article-title":"Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review","volume":"14","author":"Nittur","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0325","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.290.6476.1167","article-title":"Amphetamine, mazindol, and fencamfamin in narcolepsy","volume":"290","author":"Shindler","year":"1985","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.neurol.2016.09.018_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","article-title":"Narcolepsy","volume":"7","author":"Mitler","year":"1990","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0335","first-page":"306","article-title":"Treatment of narcolepsy with methamphetamine","volume":"16","author":"Mitler","year":"1993","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0340","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14656566.2013.783021","article-title":"Pharmacotherapy options for cataplexy","volume":"14","author":"Lopez","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neurol.2016.09.018_bib0345","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","article-title":"Cataplexy\u00a0\u2013\u00a0clinical aspects, pathophysiology and management strategy","volume":"10","author":"Dauvilliers","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0355","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40263-016-0337-4","article-title":"Treatment options for narcolepsy","volume":"30","author":"Barateau","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurol.2016.09.018_bib0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.44.4.707","article-title":"Fluoxetine suppresses human cataplexy. A pilot study","volume":"44","author":"Frey","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2016.09.018_bib0365","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp.43.2.171","article-title":"Fluvoxamine and clomipramine in the treatment of cataplexy","volume":"43","author":"Schachter","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2016.09.018_bib0375","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0380","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","article-title":"Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population","volume":"14","author":"Ohayon","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0385","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/oby.2003.156","article-title":"Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity","volume":"11","author":"Kok","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.neurol.2016.09.018_bib0390","doi-asserted-by":"crossref","first-page":"e38977","DOI":"10.1371\/journal.pone.0038977","article-title":"Non-dipping blood pressure profile in narcolepsy with cataplexy","volume":"7","author":"Dauvilliers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2016.09.018_bib0395","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0400","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0013-4694(82)90142-0","article-title":"Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence","volume":"53","author":"Mitler","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40272-014-0083-3","article-title":"Pharmacological management of narcolepsy and cataplexy in pediatric patients","volume":"16","author":"Lecendreux","year":"2014","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.neurol.2016.09.018_bib0410","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2869.2010.00824.x","article-title":"Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness","volume":"19","author":"Vernet","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2016.09.018_bib0415","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neurol.2016.09.018_bib0420","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5664\/jcsm.27658","article-title":"Idiopathic hypersomnia: clinical features and response to treatment","volume":"5","author":"Ali","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0425","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.sleep.2011.03.010","article-title":"Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy","volume":"12","author":"Lavault","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0430","first-page":"e202","article-title":"Modafinil for the treatment of idiopathic hypersomnia\u00a0\u2013\u00a0results of a randomized, double-blind, placebo controlled study","volume":"14","author":"Mayer","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0435","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5665\/sleep.3480","article-title":"Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial","volume":"37","author":"Philip","year":"2014","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jsr.12201","article-title":"Modafinil in the treatment of idiopathic hypersomnia without long sleep time\u00a0\u2014\u00a0a randomized, double-blind, placebo-controlled study","volume":"24","author":"Mayer","year":"2015","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2016.09.018_bib0445","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.sleep.2014.01.021","article-title":"Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review","volume":"15","author":"Leu-Semenescu","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0450","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.sleep.2015.10.005","article-title":"Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review","volume":"17","author":"Leu-Semenescu","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0455","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/sleep\/30.10.1274","article-title":"Idiopathic hypersomnia: a study of 77 cases","volume":"30","author":"Anderson","year":"2007","journal-title":"SLEEP"},{"key":"10.1016\/j.neurol.2016.09.018_bib0460","doi-asserted-by":"crossref","first-page":"161ra151","DOI":"10.1126\/scitranslmed.3004685","article-title":"Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors","volume":"4","author":"Rye","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2016.09.018_bib0465","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.24710","article-title":"Absence of GABA-A receptor potentiation in central hypersomnolence disorders","volume":"80","author":"Dauvilliers","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2016.09.018_bib0470","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.24459","article-title":"Clarithromycin in g-aminobutyric acid\u00a0\u2013\u00a0Related hypersomnolence: a randomized, crossover trial","volume":"78","author":"Trotti","year":"2015","journal-title":"Ann Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378716302776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T10:03:50Z","timestamp":1601201030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378716302776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0035378716302776"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2016.09.018","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French consensus. Management of patients with hypersomnia: Which strategy?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2016.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}